Exploratory Study of Precise Therapy for Advanced Tumor Patients With Malignant Hydrothorax or Ascites by Using PTC Drug Sensitivity Testing

RecruitingOBSERVATIONAL
Enrollment

55

Participants

Timeline

Start Date

August 4, 2023

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2025

Conditions
Lung CancerBreast CancerGastric CancerColorectal Cancer
Interventions
DIAGNOSTIC_TEST

Patient-derived tumor-like cell clusters (PTC) drug sensitivity testing.

Fresh malignant effusion samples were collected from advanced malignancy patients for PTC drug sensitivity testing, then assess the accuracy of this diagnostic test by combination and analysis with final clinical outcome.

Trial Locations (1)

430030

RECRUITING

Tongji Hospital, Wuhan

All Listed Sponsors
collaborator

Beijing GeneX MedLab Co., Ltd

INDUSTRY

lead

Liu Huang

OTHER